Contraindicated. Coadministration of doravirine with a robust CYP3A inducer might lessen doravirine plasma concentrations and/or effects. Prospective for loss of virologic response and probable resistance to doravirine.Immediately after stopping a CYP3A4 inducer, given that the effects in the inducer decrease, the fentanyl plasma concentration will